CERAD-neuropsychological battery in screening mild Alzheimer's disease.

  title={CERAD-neuropsychological battery in screening mild Alzheimer's disease.},
  author={Mona Sotaniemi and Veijo Pulliainen and Laura Hokkanen and Tuula A Pirttil{\"a} and Ilona Hallikainen and Hilkka Soininen and Tuomo H{\"a}nninen},
  journal={Acta neurologica Scandinavica},
  volume={125 1},
OBJECTIVES The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological battery (nb) is used as an evaluation tool for dementia. In Finland, CERAD-nb was introduced in 1999 and has been proposed to be used in primary health care. However, some of its parts need reassessment and focusing. The goal of this study was to examine the sensitivity and specificity of the subtests and their cut-off points most appropriate for identifying mild Alzheimer's disease (AD… CONTINUE READING